| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/31/2001 | CN1073849C Chinese and western medicine capsule for curing psoriasis and leucodermia in sleep |
| 10/31/2001 | CN1073848C Ginkgo flavone internal ester extract and preparation process thereof |
| 10/31/2001 | CN1073846C Partial low-released peroxide dismutase inhibitor |
| 10/31/2001 | CN1073845C Liniment film for onychomycosis and its preparation technology |
| 10/31/2001 | CN1073844C Therapeutic agent for liver regeneration |
| 10/31/2001 | CN1073843C Metastasis suppressory agents |
| 10/30/2001 | US6310252 As topical anaesthetics |
| 10/30/2001 | US6310247 7-aryl-6(Z)-heptatrienoic acid retinamides |
| 10/30/2001 | US6310226 Vitamin D analogues |
| 10/30/2001 | US6310217 Antiinflammatory and analgesic agents |
| 10/30/2001 | US6310216 Special 3-azabicyclo[3.1.0]hexanes, method for producing and modifying the same, and their use |
| 10/30/2001 | US6310213 Good affitity to the nmda receptor and they are therefore useful in the treatment of neurodegenerative diseases |
| 10/30/2001 | US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 10/30/2001 | US6310210 Water-soluble and excellent in an anti-tumor activity |
| 10/30/2001 | US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines |
| 10/30/2001 | US6310207 Mannich reaction |
| 10/30/2001 | US6310205 Intermediates for preparing 3-substituted adenines and 3,8-di-substituted 6-aminopurine derivatives for use as phosphodiesterase inhibitors. |
| 10/30/2001 | US6310203 Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands |
| 10/30/2001 | US6310202 Nitric oxide carriers based on polyazamacrocycle complexes |
| 10/30/2001 | US6310196 DNA construct for immunization or gene therapy |
| 10/30/2001 | US6310103 Administering to a mammal suffering from urinary incontinence incontinence while reducing adverse effect associted with racemic or r-enantiiomer of tolterodine, a s(-)-2-(alpha-(2-(diisopropylamino)ethyl)benzyl)-p-cresol |
| 10/30/2001 | US6310101 Administering to the mammal suffering from panic disorder an effective amount of a venlafaxine derivative |
| 10/30/2001 | US6310100 Method of treating hypertension |
| 10/30/2001 | US6310099 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 10/30/2001 | US6310098 Providing gamma-butyric acid, salt or analog which binds an alpha2delta subunit of a voltage-gated calcium channel and administering above compound to a patient experiencing hot flashes |
| 10/30/2001 | US6310097 Protecting and survival promoting agent for central nervous cell |
| 10/30/2001 | US6310096 Cyclohexadiene-derivatives as pesticides |
| 10/30/2001 | US6310094 Ready-to-use esmolol solution |
| 10/30/2001 | US6310093 Method of preventing neuronal death |
| 10/30/2001 | US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease |
| 10/30/2001 | US6310090 Process and product for enhancing immune response in companion animals using a combination of antioxidants |
| 10/30/2001 | US6310089 Composition for the administration of a D1-agonists |
| 10/30/2001 | US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors |
| 10/30/2001 | US6310087 Treating gastric or duodenal ulcer, osteoporosis, constipation, renal disorders, sexual dysfunction, baldness, diabetes, cancer and disorder of immune regulation |
| 10/30/2001 | US6310086 Indole derivatives and medicinal compositions containing the same |
| 10/30/2001 | US6310085 Method for the treatment of neurological or neuropsychiatric disorders |
| 10/30/2001 | US6310084 Inhibitors of metalloproteases involved in tissue degradation |
| 10/30/2001 | US6310082 Benzimidazole compounds |
| 10/30/2001 | US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 10/30/2001 | US6310079 Non-steroidal antiinflammatory agents |
| 10/30/2001 | US6310077 Alkylating substituted benzofurancarboxamide with 1-chloro-3-methoxypropane in solvent in presence of base or acylating 1-(3-methoxypropyl)-4-piperidinamine with substituted benzofurancarboxylic acid, forming salt if desired |
| 10/30/2001 | US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 10/30/2001 | US6310074 Substituted dimeric compounds |
| 10/30/2001 | US6310073 Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| 10/30/2001 | US6310072 Production of analgesic synergy by co-administration of sub-analgesic doses of a MU opioid agonist and a kappa-2 opioid agonist |
| 10/30/2001 | US6310068 Benzonitriles and benzofluorides |
| 10/30/2001 | US6310065 Pyridazinone hydrochloride compound and method for producing the same |
| 10/30/2001 | US6310064 Aralkyl diazabicycloalkane derivatives for CNS disorders |
| 10/30/2001 | US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors |
| 10/30/2001 | US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 10/30/2001 | US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening |
| 10/30/2001 | US6310055 Halophenoxy substituted carbapenem antibacterial compounds |
| 10/30/2001 | US6310054 Such as levonorgestrel |
| 10/30/2001 | US6310053 Complexed with an equimolar amount of a magnesium compound, and solubilized in a water miscible solvent system comprising glycerol formal and polyethylene glycol in different volumes depending on molecular weight, and a ph modifier reduction |
| 10/30/2001 | US6310052 Nitrate esters and their use for neurological conditions |
| 10/30/2001 | US6310051 By administering a dipyridoxyl based chelating agent, or a metal chelate or salt thereof, such as n,n'-bis-(pyridoxal-5-phosphate)-ethylenediamine-n,n'-diacetic acid |
| 10/30/2001 | US6310050 Therapeutic use of compounds with β3-agonist activity |
| 10/30/2001 | US6310049 Nematicidal pyrazoles |
| 10/30/2001 | US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 10/30/2001 | US6310042 Derivatives of carbohydrates and compositions containing them |
| 10/30/2001 | US6309892 Detecting immunoglobulins in sample; incubate sample with dense microspheres, monitor and measure immune reponse |
| 10/30/2001 | US6309866 6-phosphogluconate dehydrogenase |
| 10/30/2001 | US6309830 Nucleotide sequence which encodes a synthetic transfer ribonucleic acid; for use as a tool in gene therapy |
| 10/30/2001 | US6309826 Diagnosing tumors; monitor tumorous tissue for nucleotide sequences coding tumor glycoprotein, compare to amount of nucleotide sequences coding tumor glycoprotein in healthy sample, classify cells |
| 10/30/2001 | US6309687 Anti-first-pass effect compounds |
| 10/30/2001 | US6309677 Mixture of algal extract containing alpha and beta carotene, plam fruit extract containing alpha and beta carotene and a marigold flower extract containing lutein |
| 10/30/2001 | US6309672 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition |
| 10/30/2001 | US6309671 Stable glassy state powder formulations |
| 10/30/2001 | US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 10/30/2001 | US6309662 Use of anti-inflammatory drugs for treatment of dermatological conditions |
| 10/30/2001 | US6309654 Activated oxygen containing compounds for improving the microcirculation of the skin |
| 10/30/2001 | US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified. |
| 10/30/2001 | US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host. |
| 10/30/2001 | US6309646 Derivatizing a polysaccharide with thiols, amines, or hydrazides; reacting the derivatized polysaccharide with a vinylsulfone group; reacting the product with a protein, a peptide, or a hapten |
| 10/30/2001 | US6309634 Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV) |
| 10/30/2001 | US6309631 Oil-based base cream, 40-50% w/w of a 1:1 w/w mixture of titanium dioxide and ferric oxide and from 0 to 20% w/w of a melt additive; mitigation of burns |
| 10/30/2001 | US6309630 Non-steroidal anti-inflammatory ophthalmic suspensions |
| 10/30/2001 | US6309381 Use of human growth hormone to treat acute myocardial infarction |
| 10/30/2001 | CA2220178C Dry preparations containing microbially produced oil |
| 10/30/2001 | CA2216160C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 10/30/2001 | CA2165265C High hydroxyacid water in oil emulsion cosmetic or dermatologic composition |
| 10/30/2001 | CA2123101C Nitroxyalkylamide derivative |
| 10/30/2001 | CA2084669C [3h,7h]thiazolo[3,4-a]pyridines with antiasthmatic and a antiinflammatory actions on the respiratory tract |
| 10/30/2001 | CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity |
| 10/30/2001 | CA2048931C Carbamoyl-1-(pyridinylalkyl)-1h-indoles, indolines and related analogs |
| 10/30/2001 | CA2048027C 3-arylindole and 3-arylindazole derivatives |
| 10/30/2001 | CA2047843C Method and product for the treatment of gastric disease |
| 10/30/2001 | CA2037687C 7-(diphenylmethyl)oxy-9a-methoxymitosane and making and use thereof |
| 10/30/2001 | CA2029863C Compositions and methods for treating viral infections |
| 10/30/2001 | CA2025113C Agent for preventing infection with antibiotic-resistant staphylococcus |
| 10/28/2001 | CA2345284A1 Blood pressure stabilization during hemodialysis |
| 10/28/2001 | CA2314618A1 Therapeutic compositions and methods relating to prolactin releasing peptide (prrp) |
| 10/28/2001 | CA2307278A1 Use of n-heterocyclic substituted salicylic acids for inhibition of cellular uptake of cystine |
| 10/28/2001 | CA2307079A1 Inconnu |
| 10/27/2001 | CA2345180A1 Methods of treating obesity using a neurotensin receptor ligand |
| 10/25/2001 | WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 10/25/2001 | WO2001079837A1 Methylxanthines in the diagnosis and treatment of autistic disorder |
| 10/25/2001 | WO2001079557A2 Gtp-binding protein useful in treatment and detection of cancer |
| 10/25/2001 | WO2001079526A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 10/25/2001 | WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |